Patents by Inventor David M. Lubaroff

David M. Lubaroff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer vaccines and methods of producing and using same
    Patent number: 11730799
    Abstract: A method of vaccinating a subject is provided, where a cancer protective response is produced. A first vaccine comprises an adenovirus vector comprising at least one nucleic acid molecule that produces a cancer protective response is administered, followed by one or more second vaccines comprising an alphavirus replicon particle comprising RNA comprising or produced from the nucleic acid molecule. In an embodiment the cancer is prostate cancer.
    Type: Grant
    Filed: June 29, 2021
    Date of Patent: August 22, 2023
    Assignees: UNIVERSITY OF IOWA RESEARCH FOUNDATION, THE UNITED STATES GOVERNMENT DEPARTMENT OF VETERANS AFFAIRS
    Inventors: David M. Lubaroff, Delbert L. Harris
  • CANCER VACCINES AND METHODS OF PRODUCING AND USING SAME
    Publication number: 20210322529
    Abstract: A method of vaccinating a subject is provided, where a cancer protective response is produced. A first vaccine comprises an adenovirus vector comprising at least one nucleic acid molecule that produces a cancer protective response is administered, followed by one or more second vaccines comprising an alphavirus replicon particle comprising RNA comprising or produced from the nucleic acid molecule. In an embodiment the cancer is prostate cancer.
    Type: Application
    Filed: June 29, 2021
    Publication date: October 21, 2021
    Inventors: David M. Lubaroff, Delbert L. Harris
  • CANCER VACCINES AND METHODS OF PRODUCING AND USING SAME
    Publication number: 20200121774
    Abstract: A method of vaccinating a subject is provided, where a cancer protective response is produced. A first vaccine comprises an adenovirus vector comprising at least one nucleic acid molecule that produces a cancer protective response is administered, followed by one or more second vaccines comprising an alphavirus replicon particle comprising RNA comprising or produced from the nucleic acid molecule. In an embodiment the cancer is prostate cancer.
    Type: Application
    Filed: April 11, 2018
    Publication date: April 23, 2020
    Inventors: David M. Lubaroff, Delbert L. Harris